Novartis India Limited 

(Public, BOM:500672)   Watch this stock   
Find more results for 500672
Oct 22, 2009
Q3 2009 NOVARTIS INDIA LTD Earnings Release
  

Key stats and ratios

Q3 (Sep '09) 2009
Net profit margin 18.51% 15.58%
Operating margin 28.06% 25.98%
EBITD margin - 26.49%
Return on average assets - 16.57%
Return on average equity - 21.54%
Employees 875 -

Address

Sandoz House, Shivsagar Estate Dr. Annie Besant Road Worli
Mumbai, 400 018
India
+91-22-24988888 (Phone)
+91-22-22047857 (Fax)

Website links

Novartis India Limited discussions

  View all discussions »

Description

Novartis India Limited (NIL) is an India-based pharmaceutical company. The business operations of the Company include pharmaceuticals, generic, over the counter (OTC) and animal health. The Pharmaceuticals segment comprises a portfolio of prescription medicines, which are provided to patients through healthcare professionals. The Generics segment comprises retail generics products. The business unit primarily focuses on the therapeutic segments, such as anti tuberculosis, anti-dub (gynaecology), anti-histamines, antibiotics, anti-ulcerants, anti-diabetes and cardiovascular. The Animal Health segment has a presence primarily in the cattle and poultry market segments. The OTC segment is mainly in the vitamins, minerals and nutritional supplements (VMS) and cough, cold and allergy (CoCoA) market segments.

Officers and directors

Ranjit Shahani
Vice Chairman of the Board, Managing Director, Executive Director
Hemang K. Maniar
Compliance Officer, General Counsel, Company Secretary, Head - Investor Relations
P. R. Rao
Member of the Executive Committee - Animal Health
A. Matai
Member of the Executive Committee - Pharmaceuticals
V. Singhal
Member of the Executive Committee - OTC
P. Gupta
Member of the Executive Committee - Finance
C. Snook
Non-Executive Chairman of the Board
Rajen Nath Mehrotra
Non-Executive Independent Director
Age: 64
J. Hiremath
Non-Executive Independent Director